Market closed · data as of 27 Aug 2026 · source NSE via Alphave. Open the live chart →
Religare Enterprises is a diversified financial services holding company whose key asset is Care Health Insurance, a leading standalone health insurer; it also owns Religare Finvest (SME/MSME lending NBFC, recovered from a legacy fraud under previous promoters) and Religare Broking. Control passed to the Dabur-promoter Burman family following their open offer. Value is driven primarily by the health insurance subsidiary.
Religare Enterprises Ltd. is a constituent of NIFTY MICROCAP 250. See where it sits on the market heatmap →
Consolidated annual figures taken from Religare Enterprises Ltd.'s own filed statements — not estimates, and not restated by us. The most recent period shown is FY26 (year ended 31 Mar 2026).
| Metric | FY26 | FY25 | FY24 |
|---|---|---|---|
| EPS (basic, ₹) | 2.59 | 3.79 | 7.13 |
| Return on equity | 2.2% | 3.6% | 7.3% |
| Operating margin | 1.1% | 3.2% | 4.0% |
| Net margin | 0.9% | 2.5% | 5.6% |
| EBITDA | ₹136 Cr | ₹300 Cr | ₹318 Cr |
| Free cash flow | ₹1,807 Cr | ₹1,547 Cr | ₹1,478 Cr |
| Interest coverage | 2.5 | 6.4 | 2.6 |
Open the full income statement, balance sheet and cash flow for RELIGARE →
As disclosed for the quarter ended 30 Jun 2026.
Institutional ownership changes quarter to quarter. See daily FII and DII flows across the market →
Companies Alphave classifies in the same sub-sector, closest by market capitalisation.